{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:39:01Z","timestamp":1791178741104,"version":"4.1.0"},"reference-count":23,"publisher":"American Association for Cancer Research (AACR)","issue":"11","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Tumor suppressor p53 is either lost or mutated in several types of cancer. MDM2 interaction with p53 results in ubiquitination and 26S proteasomal degradation of p53. Chronic DNA damage leads to inactivation of MDM2, stabilization of p53, and apoptotic cell death. Here, we present a novel MDM2\/ubiquitination-independent mechanism of stabilization and transient activation of p53. The present studies show that 20S proteasomes degrade p53. The 20S degradation of p53 was observed in ubiquitin-efficient and -deficient cells, indicating that this pathway of degradation did not require ubiquitination of p53. The cytosolic quinone oxidoreductases [NRH:quinone oxidoreductase 2 (NQO2) and NAD(P)H:quinone oxidoreductase 1 (NQO1)] interacted with p53 and protected p53 against 20S proteasomal degradation. Further studies revealed that acute exposure to radiation or chemical leads to induction of NQO1 and NQO2 that stabilizes and transiently activates p53 and downstream genes. These results suggest that stress-induced NQO1 and NQO2 transiently stabilize p53, which leads to protection against adverse effects of stressors. [Cancer Res 2007;67(11):5380\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-0323","type":"journal-article","created":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T22:28:14Z","timestamp":1180736894000},"page":"5380-5388","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":91,"title":["NRH:Quinone Oxidoreductase 2 and NAD(P)H:Quinone Oxidoreductase 1 Protect Tumor Suppressor p53 against 20S Proteasomal Degradation Leading to Stabilization and Activation of p53"],"prefix":"10.1158","volume":"67","author":[{"given":"Xing","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labanyamoy","family":"Kole","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Iskander","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil K.","family":"Jaiswal","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2007,6,1]]},"reference":[{"key":"2022061622294681200_B1","doi-asserted-by":"crossref","unstructured":"Pietsch EC, Humbey O, Murphy ME. Polymorphisms in the p53 pathway. Oncogene\u20082006; 25: 1602\u201311.","DOI":"10.1038\/sj.onc.1209367"},{"key":"2022061622294681200_B2","doi-asserted-by":"crossref","unstructured":"Dai M, Jin Y, Gallegos JR, et al. Balance of yin and yang: Ubiquitylation-mediated regulation of p53 and c-Myc. Neoplasia\u20082006; 8: 630\u201344.","DOI":"10.1593\/neo.06334"},{"key":"2022061622294681200_B3","doi-asserted-by":"crossref","unstructured":"Ross D, Kepa JK, Winski SL, et al. NAD(P)H:quinone oxidoreductase1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphism. Chem Biol Interact\u20082000; 129: 77\u201397.","DOI":"10.1016\/S0009-2797(00)00199-X"},{"key":"2022061622294681200_B4","doi-asserted-by":"crossref","unstructured":"Long DJ II, Jaiswal AK. NRH:quinone oxidoreductase2 (NQO2). Chem Biol Interact\u20082000; 129: 99\u2013112.","DOI":"10.1016\/S0009-2797(00)00200-3"},{"key":"2022061622294681200_B5","doi-asserted-by":"crossref","unstructured":"Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med\u20082004; 36: 1199\u2013207.","DOI":"10.1016\/j.freeradbiomed.2004.02.074"},{"key":"2022061622294681200_B6","doi-asserted-by":"crossref","unstructured":"Radjendirane V, Joseph P, Lee H, et al. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem\u20081998; 273: 7382\u20139.","DOI":"10.1074\/jbc.273.13.7382"},{"key":"2022061622294681200_B7","doi-asserted-by":"crossref","unstructured":"Long DJ, Iskander K, Gaikwad A, et al. Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity. J Biol Chem\u20082002; 277: 46131\u20139.","DOI":"10.1074\/jbc.M208675200"},{"key":"2022061622294681200_B8","doi-asserted-by":"crossref","unstructured":"Gaikwad A, Long DJ II, Stringer JL, et al. In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J Biol Chem\u20082001; 276: 22559\u201364.","DOI":"10.1074\/jbc.M101053200"},{"key":"2022061622294681200_B9","unstructured":"Long DJ II, Gaikwad A, Multani A, et al. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res\u20082002; 62: 3030\u20136."},{"key":"2022061622294681200_B10","unstructured":"Long DJ II, Waikel RL, Wang XJ, et al. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res\u20082000; 60: 5913\u20135."},{"key":"2022061622294681200_B11","doi-asserted-by":"crossref","unstructured":"Long DJ II, Waikel RL, Wang XJ, et al. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst\u20082001; 93: 1166\u201370.","DOI":"10.1093\/jnci\/93.15.1166"},{"key":"2022061622294681200_B12","doi-asserted-by":"crossref","unstructured":"Iskander K, Paquet M, Brayton C, et al. Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethybenz(a)anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res\u20082004; 64: 5925\u20138.","DOI":"10.1158\/0008-5472.CAN-04-0763"},{"key":"2022061622294681200_B13","doi-asserted-by":"crossref","unstructured":"Iskander K, Gaikwad A, Paquet M, et al. Lower induction of p53 and decreased apoptosis in NQO1-null mice leads to increased sensitivity of chemical-induced carcinogenesis. Cancer Res\u20082005; 65: 2054\u20138.","DOI":"10.1158\/0008-5472.CAN-04-3157"},{"key":"2022061622294681200_B14","doi-asserted-by":"crossref","unstructured":"Asher G, Loten J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinone oxidoreductase 1. Proc Natl Acad Sci U S A\u20082001; 98: 1188\u201393.","DOI":"10.1073\/pnas.98.3.1188"},{"key":"2022061622294681200_B15","doi-asserted-by":"crossref","unstructured":"Asher G, Loten J, Kama R, et al. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A\u20082002; 99: 3099\u2013104.","DOI":"10.1073\/pnas.052706799"},{"key":"2022061622294681200_B16","doi-asserted-by":"crossref","unstructured":"Asher G, Loten J, Sachs L, et al. Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1. Proc Natl Acad Sci U S A\u20082002; 99: 13125\u201330.","DOI":"10.1073\/pnas.202480499"},{"key":"2022061622294681200_B17","doi-asserted-by":"crossref","unstructured":"Anwar A, Dehn D, Siegel D, et al. Interaction of human NAD(P)H:quinone oxidoreductase 1 (NQO1) with the tumor suppressor protein p53 in cells and cell-free systems. J Biol Chem\u20082003; 278: 10368\u201373.","DOI":"10.1074\/jbc.M211981200"},{"key":"2022061622294681200_B18","doi-asserted-by":"crossref","unstructured":"Salvat C, Acquaviva C, Scheffner M, et al. Molecular characterization of the thermosensitive E1 ubiquitin-activating enzyme cell mutant A31N-ts20. Eur J Biochem\u20082000; 267: 3712\u201322.","DOI":"10.1046\/j.1432-1327.2000.01404.x"},{"key":"2022061622294681200_B19","doi-asserted-by":"crossref","unstructured":"Kole L, Sarkar K, Mahato SB, et al. Neoglcoprotein-conjugated liposomes as macrophage-specific drug carrier in the therapy of leishmaniasis. Biochem Biophys Res Commun\u20081994; 200: 351\u20138.","DOI":"10.1006\/bbrc.1994.1455"},{"key":"2022061622294681200_B20","doi-asserted-by":"crossref","unstructured":"Ahn KS, Sethi G, Jain AK, et al. Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kB, IkBa kinase, c-Jun N-terminal kinase, akt, p38, and p44\/42 mitogen-activated protein kinases and potentiates apoptosis. J Biol Chem\u20082006; 281: 19798\u2013806.","DOI":"10.1074\/jbc.M601162200"},{"key":"2022061622294681200_B21","doi-asserted-by":"crossref","unstructured":"Segura-Aguilar J, Kaiser R, Lind C. Separation and characterization of isoforms of DT-diaphorase from rat liver cytosol. Biochim Biophys Acta\u20081992; 1120: 33\u201342.","DOI":"10.1016\/0167-4838(92)90421-9"},{"key":"2022061622294681200_B22","doi-asserted-by":"crossref","unstructured":"Sun Yi. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog\u20082006; 45: 409\u201315.","DOI":"10.1002\/mc.20231"},{"key":"2022061622294681200_B23","doi-asserted-by":"crossref","unstructured":"Lee MH, Lozano G. Regulation of the p53\u20132 pathway by 14\u20133-3 o- and other proteins. Semin Cancer Biol\u20082006; 16: 225\u201334.","DOI":"10.1016\/j.semcancer.2006.03.009"}],"updated-by":[{"DOI":"10.1158\/0008-5472.can-14-3458","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"record-id":"1597"},{"DOI":"10.1158\/0008-5472.can-14-3458","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000}}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/11\/5380\/2863365\/5380.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/11\/5380\/2863365\/5380.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T02:10:08Z","timestamp":1655431808000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/11\/5380\/532961\/NRH-Quinone-Oxidoreductase-2-and-NAD-P-H-Quinone"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":23,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2007,6,1]]},"published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-0323","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}